Here's Why You Should Retain Inari Medical (NARI) for Now [Yahoo! Finance]
Inari Medical, Inc. (NARI)
Company Research
Source: Yahoo! Finance
However, its dependency on the adoption of products is concerning. Shares of this Zacks Rank #3 (Hold) company have lost 29.5% year to date against the industry's 4.8% growth. The S&P 500 Index has risen 14.6% in the same time frame. NARI, with a market capitalization of $2.67 billion, is a commercial-stage medical device company. It seeks to develop products for treating and changing the lives of patients suffering from venous diseases. Image Source: Zacks Investment Research The company's negative earnings yield of 0.9% compares favorably with the industry's (-6.9%). It delivered a trailing four-quarter average earnings surprise of 130.74%. What's Driving NARI's Performance? Inari Medical's top-line growth is primarily driven by its ClotTriever and FlowTriever products that target the venous thromboembolism (VTE) markets, which represent significant growth opportunities going forward. The significant growth prospect in the market for Inari's VTE products should help driv
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical Lawsuit - NARIAccesswire
- Inari Medical, Inc. Sued for Securities Law Violations - Investors Should Contact The Rosen Law Firm Before July 12, 2024 to Discuss Your Rights - NARIPR Newswire
- NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAccesswire
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical, Inc. Lawsuit - NARIAccesswire
- Investors Who Have Incurred Losses In Inari Medical Inc Are Encouraged By The Schall Law Firm To Make Contact As It Begins A ProbeAccesswire
NARI
Earnings
- 4/30/24 - Miss
NARI
Sec Filings
- 6/24/24 - Form 4
- 6/20/24 - Form 4
- 6/14/24 - Form 4
- NARI's page on the SEC website